Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
B6054 EAI045Summary: Inhibitor of L858R/T790M EGFR mutants -
B5843 CTX0294885Target: KinasesSummary: Pan-kinase inhibitor -
A8706 BLU9931Target: FGFRSummary: FGFR4 inhibitor,potent and irreversible -
C8406 LomedeucitinibSummary: Lomedeucitinib (BMS-986322) acts by targeting receptor tyrosine protein kinases. -
B1150 NSI-189Summary: Nootropic and neurogenic research chemical -
C5417 AG-1557Summary: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase -
C4844 AG-183Summary: inhibitor of epidermal growth factor (EGF) receptor kinase -
C4770 AG-213Summary: inhibitor of epidermal growth factor (EGF) receptor kinase -
C4766 RG-14620Summary: inhibitor of epidermal growth factor (EGF) receptor kinase -
C4760 AG-82Summary: inhibitor of EGFR kinase
